{"disease":{"id":"susceptibility-genetic","name":"susceptibility genetic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06256419","title":"Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false},{"nct_id":"NCT06277466","title":"Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2DM and Controls","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"The Affiliated Hospital of Xuzhou Medical University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}